Showcase Your Work
This is an informal session to help you connect with your peers in a relaxed atmosphere, continuing to forge new and beneficial relationships. With an audience of biopharma experts eager to hear the latest breakthroughs in oligonucleotide chemistry and delivery, you will have the opportunity to display a poster presenting your own research. Do not miss the chance to connect, learn, and present at the Oligonucleotide Therapeutics Summit.
- Demonstrate your thought leadership in oligonucleotide chemistry and delivery
- Gain visibility and exposure in showcasing your innovations to a focused, expert audience
- Engage in meaningful discussions with industry peers to receive direct feedback
- Attract the attention of industry stakeholders and collaborators
How to Submit Your Poster
- You must first register your place to attend the 2nd Oligonucleotide-Based Therapeutics Summit
- Submit an abstract for review to showcase your poster during the Scientific Poster Session
- You will be notified once your abstract has been accepted along with details of printing and size requirements. We do request an online PDF of the poster 2 weeks prior to the summit
- Scientific Poster Session: Wednesday, December 10, 2:30 PM
- Abstract Submission Deadline: 11/23/2026
Click the 'Submit Your Poster' button below.
Please note, there is no additional charge, but you must be attending the conference to submit an abstract. Posters should not be used for sales and marketing purposes. All abstracts are subject to approval by the conference organizers, who reserve the right to reject submissions.
Explore the Full Event Guide
- Get the full agenda, speaker line-up, and session breakdown for the Oligonucleotide Therapeutics Summit, and start planning which sessions on extrahepatic delivery, conjugate design, or next-gen chemistry are must-attends for your programme
- See the breadth of modalities and disease areas on the agenda, spanning metabolic, neurological, cardiovascular and oncology applications, and pinpoint where oligonucleotide technology could unlock your next target
- Meet the faculty shaping the field, from Directors of Oligonucleotide Chemistry to VPs of Platform Discovery and CSOs, with over half our confirmed speakers holding Director-level roles or above
- Check out sessions unveiling entirely new, never-before-seen data, including groundbreaking work on aptamers, before it's presented anywhere else
- See who else is in the room, from CMC leads to translational biology VPs across pharma and biotech, and start planning the conversations worth having before you arrive
